GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANWA) » Definitions » Accumulated other comprehensive income (loss)

Immuron (FRA:ANWA) Accumulated other comprehensive income (loss) : €1.98 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Immuron Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Immuron's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was €1.98 Mil.

Immuron's quarterly Accumulated other comprehensive income (loss) declined from Dec. 2022 (€2.06 Mil) to Jun. 2023 (€2.01 Mil) and declined from Jun. 2023 (€2.01 Mil) to Dec. 2023 (€1.98 Mil).

Immuron's annual Accumulated other comprehensive income (loss) declined from Jun. 2021 (€2.20 Mil) to Jun. 2022 (€2.11 Mil) and declined from Jun. 2022 (€2.11 Mil) to Jun. 2023 (€2.01 Mil).

Immuron Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Immuron's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron Accumulated other comprehensive income (loss) Chart

Immuron Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only 2.64 0.69 2.20 2.11 2.01

Immuron Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.07 2.11 2.06 2.01 1.98

Immuron Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Immuron Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Immuron's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuron (FRA:ANWA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANWA) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
ASX:NOX ASX:ACR ASX:CHM ASX:1AI ASX:ATX ASX:ATH ASX:PAB ASX:RAD ASX:BTC ASX:1AD OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
IMRN:USA IMC:Australia
Address
Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130
Website
https://www.immuron.com.au
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Immuron (FRA:ANWA) Headlines

No Headlines